Paper36940798
Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ and 19 others. Kidney Int, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events. Papers, record 36940798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36940798
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Podocytes | Major topic |
| Nephrotic Syndrome | Major topic |
| Glomerulosclerosis, Focal Segmental | Major topic |
| Animals | |
| Humans | |
| TRPC6 Cation Channel | |
| Receptor, PAR-1 | |
| Disease Models, Animal | |
| Recurrence |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0800200 | Medical Research Council | United Kingdom | PubMed | |
| MR/K010492/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/L002418/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/R003017/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/T002263/1 | Medical Research Council | United Kingdom | PubMed | |
| MR/W019582/1 | Medical Research Council | United Kingdom | PubMed | |
| G0501901 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 37479383 | Stage lighting on PAR-1: a step further in the understanding of acquired focal and segmental glomerulosclerosis. | https://conductscience.org/library/papers/37479383 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28214467 | Paxillin: a crossroad in pathological cell migration. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28214467 | PubMed |
| 2 | 21450528 | Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. | Clin Immunol | 2011 | https://conductscience.org/library/papers/21450528 | PubMed |
| 3 | 27618774 | Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice. | Sci Rep | 2016 | https://conductscience.org/library/papers/27618774 | PubMed |
| 4 | 24744860 | Differential effects of Smad3 targeting in a murine model of chronic kidney disease. | Physiol Rep | 2013 | https://conductscience.org/library/papers/24744860 | PubMed |
| 5 | 26892346 | TRPC6 G757D Loss-of-Function Mutation Associates with FSGS. | J Am Soc Nephrol | 2016 | https://conductscience.org/library/papers/26892346 | PubMed |
| 6 | 23436459 | Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1. | J Pathol | 2013 | https://conductscience.org/library/papers/23436459 | PubMed |
| 7 | 10662791 | Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. | J Exp Med | 2000 | https://conductscience.org/library/papers/10662791 | PubMed |
| 8 | 20685822 | TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20685822 | PubMed |
| 9 | 17197445 | Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17197445 | PubMed |
| 10 | 31877991 | TRPC Channels in Proteinuric Kidney Diseases. | Cells | 2019 | https://conductscience.org/library/papers/31877991 | PubMed |
| 11 | 28424276 | Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent. | J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28424276 | PubMed |
| 12 | 29022104 | Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances. | Pediatr Nephrol | 2018 | https://conductscience.org/library/papers/29022104 | PubMed |
| 13 | 19232718 | Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells. | Cell Calcium | 2009 | https://conductscience.org/library/papers/19232718 | PubMed |
| 14 | 30443016 | Effector and regulatory B cells in immune-mediated kidney disease. | Nat Rev Nephrol | 2019 | https://conductscience.org/library/papers/30443016 | PubMed |
| 15 | 32758574 | Pharmacological and genetic inhibition of TRPC6-induced gene transcription. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32758574 | PubMed |
| 16 | 18772335 | Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. | Am J Pathol | 2008 | https://conductscience.org/library/papers/18772335 | PubMed |
| 17 | 22533598 | Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22533598 | PubMed |
| 18 | 28117080 | Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. | Kidney Int | 2017 | https://conductscience.org/library/papers/28117080 | PubMed |
| 19 | 27733370 | Protease-activated receptors in kidney disease progression. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/27733370 | PubMed |
| 20 | 10413505 | Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail. | Biochemistry | 1999 | https://conductscience.org/library/papers/10413505 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41910486 | Dysregulated Protease Homeostasis Defines Primary FSGS. | Kidney360 | 2026 | https://conductscience.org/library/papers/41910486 | PubMed |
| 41788620 | Molecular mechanisms in podocytopathies: finding suitable targets for a new era of glomerular gene therapy. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/41788620 | PubMed |
| 41517469 | The Influence of PAR 1 and Endothelin 1 on the Course of Specific Kidney Diseases. | J Clin Med | 2025 | https://conductscience.org/library/papers/41517469 | PubMed |
| 41009719 | Mechanisms and Therapeutic Perspectives of Podocyte Aging in Podocytopathies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009719 | PubMed |
| 40364208 | The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis Types. | J Clin Med | 2025 | https://conductscience.org/library/papers/40364208 | PubMed |
| 40244049 | Serine proteases and protease-activated receptors signaling in the kidney. | Am J Physiol Cell Physiol | 2025 | https://conductscience.org/library/papers/40244049 | PubMed |
| 40152945 | Effects of Prothrombin on Podocytopathy and Proteinuria in Glomerular Disease. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40152945 | PubMed |
| 39946431 | Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review. | PLoS One | 2025 | https://conductscience.org/library/papers/39946431 | PubMed |
| 39883133 | Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome. | Pediatr Nephrol | 2025 | https://conductscience.org/library/papers/39883133 | PubMed |
| 39434922 | Gene therapy and kidney diseases. | Mol Ther Methods Clin Dev | 2024 | https://conductscience.org/library/papers/39434922 | PubMed |
| 39143823 | Association between hypothyroidism and nephrotic syndrome: a bidirectional two-sample Mendelian randomization analysis. | Ren Fail | 2024 | https://conductscience.org/library/papers/39143823 | PubMed |
| 38984988 | PAR1-mediated Non-periodical Synchronized Calcium Oscillations in Human Mesangial Cells. | Function (Oxf) | 2024 | https://conductscience.org/library/papers/38984988 | PubMed |
| 38641658 | Calcium signalling and transport in the kidney. | Nat Rev Nephrol | 2024 | https://conductscience.org/library/papers/38641658 | PubMed |
| 38341276 | Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group. | Nephrol Dial Transplant | 2024 | https://conductscience.org/library/papers/38341276 | PubMed |
| 37722138 | Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy. | Diabetes | 2023 | https://conductscience.org/library/papers/37722138 | PubMed |
| 36952039 | What is circulating factor disease and how is it currently explained? | Pediatr Nephrol | 2023 | https://conductscience.org/library/papers/36952039 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36940798
GET https://conductscience.org/api/papers/v1/36940798/references?page=2